Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Gut microbIota AnalysiS of an Oral Microbiotherapy in Amyotrophic Lateral Sclerosis; an Open-label Phase 1b Pilot Trial

NCT05889572 is registered in ClinicalTrials.gov with MaaT Pharma as lead sponsor.

NCT NCT05889572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05889572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Gut microbIota AnalysiS of an Oral Microbiotherapy in Amyotrophic Lateral Sclerosis; an Open-label Phase 1b Pilot Trial
Lead sponsor
MaaT Pharma
Phase
Phase 1
Overall status
Completed
Start date
June 8, 2023
Completion date
July 22, 2024
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

als, amyotrophic lateral sclerosis